Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2006) 11 P458

N4 Clinical Hospital, Tbilisi, Georgia.


Aim: To study the carbohydrate metabolism in patients with Itsenko-Kushing’s disease (IKD) and Itsenko-Kushing’s syndrome (IKS).

Materials and Methods: 23 patients with hypercorticism were investigated. From which in 8 patients IKD was diagnosed, and in 15 – IKS. In patients with IKD the amount of cortizol was at 8.00 – 273.3±56.8 ng/ml (N- 50–250 ng/ml); 20.00 – 343.3±43.8 ng/ml (N- 50–250 ng/ml); the value of adrenocorticotropic hormone was – 89.01±7.3 pg/ml (N- 4.7–41.0 pg/ml). In patients with IKS the amount of cortizol was at 8.00 – 246.3±23.8 ng/ml (N- 50–250 ng/ml); 20.00 – 287.7±32.5 ng/ml (N- 50–250 ng/ml); the value of adrenocorticotropic hormone was – 3.6±2.7 pg/ml (N- 4.7–41.0 pg/ml). For the study of the carbohydrate metabolism we determined the fasting glucose and glycosylated hemoglobin (HbA1C).

Results: In patients with IKD the level of HbA1C was >7.5 mcm/frghb (N- 3.5–7.5), and glucose ranged in – 120–150 mg/dl in 3 patients. In patients with IKS the HbA1C was >7.5 mcm/frghb in 9 patients, and the glucose – >120 ng/dl in 12 patients. Against a background of the treatment of the primary disease the carbohydrate metabolism was normalized in 2 patients with IKD and in 10 patients with IKS. In the rest of the patients we observed the type 2 diabetes.

Conclusions: About the state of the carbohydrate metabolism we have to judge not only by the determination of the fasting glucose, but also by HbA1C (every 3 month). The normalization of the carbohydrate metabolism is related with hypercorticism normalization.

Volume 11

8th European Congress of Endocrinology incorporating the British Endocrine Societies

European Society of Endocrinology 
British Endocrine Societies 

Browse other volumes

Article tools

My recent searches

No recent searches.